Publication:
Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma

dc.contributor.authorsKargi, A; Yorukoglu, K; Aktas, S; Cakalagaoglu, F; Ermete, M
dc.date.accessioned2022-03-12T16:57:19Z
dc.date.accessioned2026-01-10T19:15:49Z
dc.date.available2022-03-12T16:57:19Z
dc.date.issued1996
dc.description.abstractSpecimens from 40 cases of thyroid carcinomas, including 35 papillary, 2 follicular, 2 undifferentiated, and 1 Hurtle cell carcinoma were analyzed for neuroendocrine differentiation with immunohistochemical tests for synapthophysin, neuron-specific enolase (NSE), chromogranin, and calcitonin; all cases were stained for thyroglobulin. Histologically, none of the cases resembled a medullary carcinoma. Twenty-five percent (10 cases) were immunoreactive for one, 30% (12 cases) for two, and 15% (6 cases) for three markers. Three of the cases that were positive for all 3 markers (7.5% of all total) had diffuse strong immunoreactivity. These results demonstrated neuroendocrine differentiation may occur in non-neuroendocrine thyroid tumors and may support the postulation that endodermally derived ultimobronchial stem cells might give rise to C cells as well as follicular cells.
dc.identifier.doidoiWOS:A1996UZ44100009
dc.identifier.issn1050-7256
dc.identifier.pubmed8837328
dc.identifier.urihttps://hdl.handle.net/11424/226920
dc.identifier.wosWOS:A1996UZ44100009
dc.language.isoeng
dc.publisherMARY ANN LIEBERT INC PUBL
dc.relation.ispartofTHYROID
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMEDULLARY
dc.subjectENDOCRINE
dc.titleNeuroendocrine differentiation in non-neuroendocrine thyroid carcinoma
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage210
oaire.citation.issue3
oaire.citation.startPage207
oaire.citation.titleTHYROID
oaire.citation.volume6

Files